Rein Therapeutics Inc
RNTX
NASDAQ
Biotechnology
$0.81
USD
+0.02 (+2.35%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $67.66M
Volume 210.9K
Price Target
$8.00 – $8.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $8.00 and a min estimate of $8.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$8.00
Implied Upside
+887.6%
Analyst Covering
1
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Brandon Folkes | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SPRO
Spero Therapeutics Inc
$1.23
▼ -0.8%
ELTX
Elicio Therapeutics Inc
$3.09
▼ -1.9%
PMVP
PMV Pharmaceuticals Inc
$1.26
▲ +3.7%
IBIO
iBio Inc
$1.43
▲ +2.1%
DWTX
Dogwood Therapeutics Inc
$2.15
▲ +8.6%
RNXT
RenovoRx Inc
$1.40
▲ +11.1%
CYPH
Cypherpunk Technologies Inc
$0.6400
▼ -0.6%
TENX
Tenax Therapeutics Inc
$1.80
▼ -1.6%
XBIT
XBiotech Inc
$2.30
▼ -1.3%
MNOV
MediciNova Inc
$1.31
▲ 0.0%